Fatty Liver Disease and Elevated Ferritin

Introduction to Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of elevated ferritin levels, accounting for over 90% of hyperferritinemia cases in outpatients when combined with other metabolic and inflammatory conditions, according to the American Association for the Study of Liver Diseases 1, 2

In NAFLD, elevated ferritin typically reflects hepatocellular injury and insulin resistance rather than actual iron accumulation, as stated by the European Association for the Study of the Liver 2
Ferritin acts as an acute phase reactant that rises during inflammation independent of actual iron stores, as noted by the American College of Gastroenterology 2

The key to distinguishing NAFLD-related hyperferritinemia from true iron overload is measuring transferrin saturation alongside ferritin, as recommended by the American Gastroenterological Association 1, 3, 4
Initial evaluation should include fasting transferrin saturation and serum ferritin measured simultaneously, as suggested by the European Association for the Study of the Liver 1, 5, 6
Liver enzymes (ALT, AST) should be assessed to evaluate hepatocellular injury, as recommended by the American Association for the Study of Liver Diseases 1, 2

If transferrin saturation <45% with elevated ferritin, NAFLD-related inflammation is the likely cause, not iron overload, according to the American College of Gastroenterology 1, 2, 4
If transferrin saturation ≥45% with elevated ferritin, proceed with HFE genetic testing for C282Y and H63D mutations to evaluate for hereditary hemochromatosis, as recommended by the American Gastroenterological Association 1, 5, 4

Never use ferritin alone without transferrin saturation to diagnose iron overload, as warned by the European Association for the Study of the Liver 2, 4, 7, 1, 5

Treatment should target the underlying NAFLD rather than the elevated ferritin itself when transferrin saturation is normal, as stated by the American Association for the Study of Liver Diseases 4
Weight loss and lifestyle modifications are recommended, as suggested by the American Gastroenterological Association 8, 8
Management of metabolic syndrome components is also recommended, as noted by the American College of Gastroenterology 1, 8

Liver biopsy should be considered in NAFLD patients with ferritin >1000 μg/L, elevated liver enzymes, or age >40 years to assess for advanced fibrosis, as recommended by the American Association for the Study of Liver Diseases 1, 5